companydata.dkBioMed Invest ApS: Financial statements 2023
CVR: 29844925
BioMed Invest ApS (CVR 29844925) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 22,558 and a net result of DKK 617,481 compared with DKK -877,690 the year before. That is an increase of 7.1% compared with the year before. Equity amounted to DKK 8,369,184. The solvency ratio was 99.5%. The company had 2 employees in the financial year.
- Gross Profit
- 22,558 kr.
- Profit/Loss
- 617,481 kr.
- Equity
- 8,369,184 kr.
- Total Assets
- 8,414,830 kr.
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 23 t. | 617 t. | 8.4 mio. | 2 |
| 2022 | - | 21 t. | -878 t. | 7.8 mio. | 2 |
| 2021 | - | 246 | 7.3 mio. | 8.6 mio. | 1 |
| 2020 | - | 28 t. | 6 t. | 1.4 mio. | - |
| 2019 | - | -16 t. | 17 t. | 1.5 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BioMed Invest ApS has published its annual report for 2022. Gross profit came to DKK 21,062, and the net result was DKK -877,690.
About BioMed Invest ApS
BioMed Invest ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2006. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Erling Henningsen. The company is owned by Erling Henningsen. In 2025, the company reported a gross profit of DKK 12,474 and a net result of DKK -80,320 compared with DKK 451,303 the year before. Equity amounted to DKK 8,740,167.